These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 28662825)

  • 1. Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target.
    Parrish AR
    Prog Mol Biol Transl Sci; 2017; 148():31-65. PubMed ID: 28662825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of matrix metalloproteinases in renal pathophysiologies.
    Catania JM; Chen G; Parrish AR
    Am J Physiol Renal Physiol; 2007 Mar; 292(3):F905-11. PubMed ID: 17190907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.
    Zakiyanov O; Kalousová M; Zima T; Tesař V
    Adv Clin Chem; 2021; 105():141-212. PubMed ID: 34809827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.
    Narula S; Tandon C; Tandon S
    Curr Med Chem; 2018; 25(15):1805-1816. PubMed ID: 29210632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in matrix metalloproteinases and their inhibitors in kidney transplant recipients.
    Ahmed AK; El Nahas AM; Johnson TS
    Exp Clin Transplant; 2012 Aug; 10(4):332-43. PubMed ID: 22845765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal.
    Zakiyanov O; Kalousová M; Zima T; Tesař V
    Kidney Blood Press Res; 2019; 44(3):298-330. PubMed ID: 31185475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of matrix metalloproteinases (MMP) and their tissue inhibitors (TIMP) in nephrology].
    Wasilewska A; Taranta-Janusz K; Zoch-Zwierz W; Rybi-Szumińska A; Kołodziejczyk Z
    Przegl Lek; 2009; 66(9):485-90. PubMed ID: 21033407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney Fibrosis and Matrix Metalloproteinases (MMPs).
    La Russa A; Serra R; Faga T; Crugliano G; Bonelli A; Coppolino G; Bolignano D; Battaglia Y; Ielapi N; Costa D; Michael A; Andreucci M
    Front Biosci (Landmark Ed); 2024 May; 29(5):192. PubMed ID: 38812325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
    Mroczko B; Groblewska M; Barcikowska M
    J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.
    Vanhoutte D; Heymans S
    J Mol Cell Cardiol; 2010 Mar; 48(3):445-53. PubMed ID: 19799912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of TIMPs in regulation of extracellular matrix proteolysis.
    Arpino V; Brock M; Gill SE
    Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer.
    Groblewska M; Siewko M; Mroczko B; Szmitkowski M
    Folia Histochem Cytobiol; 2012 Apr; 50(1):12-9. PubMed ID: 22532131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The TIMPs tango with MMPs and more in the central nervous system.
    Crocker SJ; Pagenstecher A; Campbell IL
    J Neurosci Res; 2004 Jan; 75(1):1-11. PubMed ID: 14689443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of fibrinolysis in chronic liver injury (with special emphasis on MMPs and TIMPs).
    Roderfeld M; Hemmann S; Roeb E
    Z Gastroenterol; 2007 Jan; 45(1):25-33. PubMed ID: 17236118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.